Letters sent to healthcare professionals in April 2018

Letters were sent about insulin Fiasp and Tresiba and Inhixa (enoxaparin sodium); use survey to feedback your thoughts on Direct Healthcare Professional Communications (DHPCs) and on the way medicines safety issues are communicated.

In April 2018, letters were sent to healthcare professionals about:

Finally, complete this 10-minute survey to tell us your views on the way medicines safety issues are communicated and how we might improve this to better support safe and effective use.

Article citation: Drug Safety Update volume 11 issue 10; May 2018: 3.

Published 24 May 2018